AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
TL;DR
Contin improvements in antibody engineering, linker optimization, payload development, computational modeling, and biomarker-guided patient selection are expected to further improve the therapeutic index and translational success of bsADCs in cancer treatment.
BSAbs and bsADCs provide opportunities to improve tumor selectivity, enhance internalization, overcome antigen escape, and expand the population of CRC patients eligible for targeted therapy, as well as discussing the major challenges facing clinical translation.
The structural design principles, delivery barriers, pharmacokinetic considerations, applications, imaging advancements, and current clinical landscape of PDCs are discussed, highlighting their advantages over ADCs and outlining future directions for precision oncology.
Preclinical investigation of trastuzumab-encapsulated actinomycin D, a HER2-targeted AED, has demonstrated potent antitumor activity across cancer models with varying HER2 expression levels, alongside a favorable toxicity profile in animal models, position AED as a promising next-generation targeted cancer therapy that...
In mouse xenograft models, the dual-targeting BsADC showed potential anti-tumor activity compared to single-target controls, with no overt body weight loss or observable physical toxicity detected during treatment.
This review systematically dissects the applications of BsAbs in tumor immunotherapy, focusing on rational target combinations, underlying immunological mechanisms, and clinical therapeutic potential, while critically evaluating the advantages and limitations of representative BsAb modalities.
Continual advances in molecular engineering and precision biomarker strategies are redefining ADCs as versatile platforms for precision oncology and may enable broader, potentially tumor-agnostic, applications in solid tumors.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.